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Abstract
Background: The diagnosis of dementia in primary care is perceived as a problem across countries and systems, 
resulting in delayed recognition and adverse outcomes for patients and their carers. Improving its early detection is an 
area identified for development in the English National Dementia Strategy 2009; there are thought to be multiple 
benefits to the patient, family, and resources by doing this. The aim of this review was to carry out a rapid appraisal in 
order to inform the implementation of this policy.
Method: Publications in English up to August 2009 relating to barriers to the recognition of dementia, were identified 
by a broad search strategy, using electronic databases MEDLINE, EMBASE, and psycINFO. Exclusion criteria included 
non-English language, studies about pharmacological interventions or screening instruments, and settings without 
primary care.
Results: Eleven empirical studies were found: 3 quantitative, 6 qualitative, and 2 with mixed methodologies. The main 
themes from the qualitative studies were found to be lack of support, time constraints, financial constraints, stigma, 
diagnostic uncertainty, and disclosing the diagnosis. Quantitative studies yielded diverse results about knowledge, 
service support, time constraints, and confidence. The factors identified in qualitative and quantitative studies were 
grouped into 3 categories: patient factors, GP factors and system characteristics.
Conclusion: Much can still be done in the way of service development and provision, GP training and education, and 
the eradication of stigma attached to dementia, to improve the early detection and management of dementia. 
Implementation of dementia strategies should include attention to all three categories of barriers. Further research 
should focus on their interaction, using different methods from studies to date.
Background
There are approximately 700,000 people living with
dementia in the UK today, and the number is set to dou-
ble by 2040, resulting in current costs of care of £17 bil-
lion spiraling to £50 billion each year [1]. Similar
demographic shifts in all industrialized countries will
produce similar increases in the prevalence of dementia
syndrome, with the impact being greatest in lower and
middle income countries [2]. Dementia is one of the lead-
ing causes of disability for older people. From a Global
Burden of Disease perspective it contributes 11.2% of all
y e a r s  l i v e d  w i t h  d i s a b i l i t y  w h i c h  i s  h i g h e r  t h a n  s t r o k e
(9.5%), heart disease (5%) and cancer (2.4%) [3]. From a
primary care perspective however, dementia may not
impact greatly on the workload of an average General
Practitioner, who might currently diagnose one or two
new patients each year (in a demographically average
area) and have 12 to 15 patients with dementia in a list of
2000 [4]. This workload will change as populations age.
This changing demography challenges governments
and other health care providers to develop and improve
services to people with dementia, with an emphasis on
earlier diagnosis, provision of support in the community,
and the role of primary care services [5,6]. National plans
for the development of dementia services have appeared
in France, the Netherlands, Norway, Cyprus, England [7],
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Australia [8] and New Zealand [9]. The English National
Dementia Strategy [1] sees General Practitioners (GPs) as
being well placed to recognise the symptoms and signs of
early dementia, and to trigger the necessary investiga-
tions to establish a diagnosis [9]. However, position does
not necessarily lead to action, and there appear to be bar-
riers to recognition of dementia in primary care.
There are concerns about diagnosing dementia because
of potential negative impacts on the patient (e.g. stigma,
missing a different and treatable diagnosis like depres-
sion), the caregiver (longer time in a stressful role), and
service provision (overloading of specialist services, diag-
nostic uncertainty, difficulty in changing provision) [10].
In contrast, there are thought to be a wide range of bene-
fits to the patient, the family and caregivers, and to
resources and services, in diagnosing dementia earlier,
and it has been suggested that these far outweigh the
risks. For example, timely diagnosis enables the early ini-
tiation of treatment (including pharmacological treat-
ment), and it has been shown that this can delay
admission to nursing homes and time to dependency
[11,12]. In addition, earlier diagnosis can prolong the
early phase of the condition, thus shortening the moder-
ate to severe stage, and its associated burdens [13]. Earlier
detection would also allow the opportunity to plan for the
future, and promote awareness of relevant support agen-
cies and organisations [14]. This can also help relieve the
psychological distress experienced by caregivers [15].
Despite this, early detection of dementia is difficult to
achieve in primary care across different health care sys-
tems [16-18] with diagnosis taking between 18 to 30
months, and in the extreme, up to 4 years [19]. There
have been a number of reviews of the reasons for this dif-
ficulty, and the barriers involved in diagnosing dementia
in a timely manner. Firstly, detection could be delayed for
reasons attributable to the patient, the patient's family, or
caregiver. The symptoms of dementia may not be recogn-
ised by the patient or family, and some of the early char-
acteristics such as memory loss, functional disability, or
emotional lability might be thought to be a 'normal' com-
ponent of ageing [20]. Dementia in itself results in lack of
insight and so many patients are unaware that they have a
problem [21]. This could delay diagnosis in isolated
patients who live alone, and often it is the caregivers who
make an initial diagnosis [18]. In addition, the stigma that
can be attached to the condition may prevent the patient
or family from seeking medical help, because of embar-
rassment, shame, or uncertainty [22].
Primary care practitioners may also be responsible for a
delay in reaching a diagnosis for a variety of reasons such
as knowledge gaps [14], the lack of a definitive diagnostic
test leading to diagnostic uncertainty and concerns of
mis-labelling patients [10,22], and stigma within the
medical profession. This hypothesis is supported by Eef-
sting et al's study [23] which showed that when a label of
'cognitive impairment' was used, the sensitivity of diagno-
sis by GPs improved. Other reasons that might influence
GPs are the amount of time necessary to invest in what is
often a hypothetico-deductive and longitudinal process
of diagnosis [14], the (lack of) financial reimbursement,
and the perception that making the diagnosis produces
little practical benefit for the patient [24].
Specialist services for the management of patients with
dementia ha ve been varied in the UK. T his has led to
uncertainty on the part of the GPs about access to
resources, which may have contributed to a variable qual-
ity of management delivered to the patient. It is only with
the growth in interest in dementia services that an effort
has been made to ensure that services are uniform, that
adequate training and development are provided for
health care professionals, and that regular monitoring
and evaluation of service provision takes place [1].
The aim of this review is to systematically investigate
current evidence about the barriers to dementia diagnosis
in primary care, in order to address and overcome them.
Because the implementation of the National Dementia
Strategy is already underway in England we carried out a
rapid appraisal of the literature to help inform strategy
implementation at an early stage. Because the English
National Dementia Strategy is only one of a raft of policy
initiatives across the world we believe our findings may
be relevant to other countries.
Method
Search strategy
A rapid appraisal approach was adopted to inform the
current implementation of policy. Health care policy is
influenced by many factors other than research evidence,
including political pressure, ideological stance and the
need to take action. Influencing policy development and
implementation is now an issue for researchers in all
those countries with government-driven dementia strate-
gies, and as Black has pointed out [25], timing is impor-
tant: "Windows of opportunity to make change open up
only rarely and briefly, when policy makers' values hap-
pen to coincide with the implications of research".
A systematic search for articles in the English language
pertaining to the detection of dementia in the community
was made using the electronic databases MEDLINE,
EMBASE, and psycINFO, without restricting the date or
language of publication. Searches were carried out
between May and August 2009. A broad research strategy
was adopted using the terms listed:
Dementia OR Cognitiv* Impair* OR Alzheimer's Dis-
ease
AND
Primary Care OR General Practi* OR Family Pract*
ANDKoch et al. BMC Family Practice 2010, 11:52
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Diagnos* OR Manag*
AND
Educat*
A two-step process was carried out in the electronic
search, with educat* added as the second step, after all
the other search terms. The terms used were text words
that were searched for in the abstracts. Bibliographies of
articles discovered were examined for additional relevant
literature.
Search selection
This search resulted in a total of 4311 articles being iden-
tified in the various databases, although many of these
were duplicates. To prevent narrowing of the search
scope and therefore potentially reducing the search sensi-
tivity, the terms were not refined, but instead each title
was reviewed - with its abstract if available - in order to
ascertain its relevance. A number of exclusion criteria
were applied. All studies about pharmacological interven-
tions (for dementia or Alzheimer's Disease) were
excluded, as were studies relating to the validity or useful-
ness of specific cognitive function tests. If the searches
identified articles about the diagnosis or treatment of
dementia in anywhere but a primary care setting (for
example, the benefits of respite in long-term care facili-
ties), if the article related to a cohort that was not relevant
to this review (for example the evidence for various inter-
ventions for care-giver health), or if the paper was merely
a clinical discussion about dementia diagnoses or care,
then it was excluded. Letters were also excluded, as were
publications in languages other than English.
After applying these criteria, 160 articles remained, but
seventy of these were unavailable or unobtainable online
and these were also excluded for pragmatic reasons. A
main objective of the review was to inform the imple-
mentation of the National Dementia Strategy [1], which is
already underway. Because it would take a significant
amount of time to locate and access the articles that were
not readily available, which would delay the dissemina-
tion of the results of the review, we opted to exclude the
seventy. Moreover, this review - rather than systemati-
cally aggregating data - has adopted a more interpretive
approach [26], the purpose of which is to construct theo-
ries grounded in the research, develop an understanding
about the origins of the barriers, and to generate practical
methods to overcome the barriers, through changing
practice and through well-designed future research.
Data Extraction
Each of the remaining articles were scrutinised by the two
authors (SI & TK), and subsequently categorised into one
of three topics. These were: 1) barriers to diagnosis and/
or care, 2) studies of or guidelines about diagnosis and
management, and 3) studies of changing provision or
practice in dementia care in the community. Figure 1
shows the search process, presented according to
PRISMA guidelines [27].
Discrepant categorisations were discussed between the
two authors and agreements reached as to which cate-
gory the paper fell into. For the purposes of this review,
studies of barriers to diagnosis or care were examined
and data tabulated, to enable the comparison of evidence.
The elements examined for comparison included: loca-
tion and type of study, number of participants, recruit-
ment process, methodology, data analysis, results, and
conclusions. Significant references found in relevant arti-
cles were explored and data extracted accordingly.
Results
Eleven primary research studies were identified. Of these,
six were qualitative, three were purely quantitative and
two used mixed methodologies. Because Primary Care
Physicians (PCPs) have different titles (General Practitio-
ners [GPs], Family Physicians [FPs]) in different coun-
tries, for the purposes of this article we refer to all doctors
in this category as PCPs, unless there is a specific reason
for identifying a country-specific label.
Five out of the eight qualitative or mixed studies
involved interviews or focus groups with PCPs. The
remaining three also included other health care profes-
sionals who worked with dementia patients (for example
specialist doctors, community nurses), or patients or car-
ers. The quantitative studies about barriers to care all
involved questionnaires completed by PCPs, with sample
sizes ranging from 116 (35% response rate) [28] to 1005
Figure 1 PRISMA flowchart for Barriers systematic review.
No. of additional records identified 
through other sources 2
No. of records removed because 
duplicates, non-English, 
pharmacological intervention studies
4153
No. of records screened 
160
No. of records excluded 
because not accessible
70
90 full-text articles 
assessed for eligibility 
79 full text articles 
excluded; clinical 
reviews, guidelines, 
intervention studies or 
service delivery 
descriptions without 
exploration of barriers 
11 studies included in qualitative 
synthesis
4311 records identified 
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(55% response rate) [29]. The response rates of the stud-
ies ranged from 28% (n = 127) [30] to 67% (n = 153) [16].
Six themes emerged powerfully from the research: Lack
of support, time and financial constraints, stigma, diag-
nostic uncertainty and disclosure of the diagnosis.
1. Lack of Support for patient, caregiver, or PCP
All studies identified lack of support, in one capacity or
other, as being a major barrier to the detection or man-
agement of dementia. This lack of support could take
many forms:
• Concerns about the dearth of caregiver support and 
education [27]
• Insufficient resources for the PCP to provide as 
much support as sometimes may be expected of them 
[28]
• Lack of support for the PCP with limited access to 
secondary services [29,30]. Olafsdottir et al [16] dem-
onstrated that only 43% of PCPs were satisfied with 
the specialist input that their patients received (which 
was similar to the Audit Commission's [29] finding of 
50.2%).
• Lack of knowledge about or access to community 
services and resources [31,32]. In Turner et al's study 
[30], only 45% of the PCPs knew about patient-sup-
port services, and 53% knew details of the local mem-
ory clinic. 56% of them felt that organizing the 
necessary social support services was the most diffi-
cult aspect of care [16].
• The absence of interdisciplinary teams to enhance 
management [28,31], with 43% of PCPs feeling care 
could be improved with the addition of a dementia-
trained care coordinator in the primary care centre 
[16].
2. Time Constraints
The PCPs felt that they did not have time ring-fenced in
their normal schedule to carry out the necessary proce-
dures, tests and reviews that are needed in order to make
a diagnosis of dementia [32,28,31], and this was corrobo-
rated by the quantitative studies (83% of those asked in
Turner et al [30], 69% in Olafsdottir et al [16]).
3. Financial Constraints
Inadequate financial remuneration (especially in coun-
tries where PCPs are paid according to services they pro-
vide) was proposed by PCPs as a barrier in the qualitative
research [33,28,31,34], and was confirmed in one quanti-
tative study (46% of PCPs in Turner et al [30]).
4. Stigma
Several studies mentioned concerns about stigma, attrib-
uted by the patient or caregiver on receiving a diagnosis
of dementia [35]. This may develop as a result of a num-
ber of fears, from being labelled as having a mental ill-
ness, to loss of independence or autonomy, or having to
go into a nursing home [33]. Some PCPs themselves
seemed to attach stigma to the condition of dementia by
assuming that the patient/caregiver did not want a diag-
nosis until such time that the symptoms were so severe
that it was inevitable [34].
5. Diagnostic Uncertainty
Many of the PCPs interviewed expressed concern about
uncertainties around making the diagnosis, arising from
several perspectives. Some felt that their training for this
either as under- or post-graduates had been inadequate
and did not feel confident enough to make the diagnosis
[34,36], whilst others felt that because at early stages the
manifestation of the condition was slow and fluctuating
and often overlapped by co-morbidities, or the boundary
between cognitive impairment and 'normal ageing' can be
blurred, it made the diagnosis particularly complicated to
make accurately [32,33,28]. Quantitatively, PCPs in two
studies felt they did not have sufficient knowledge of or
training about the condition (80% in Olafsdottir et al [16],
and 52.4% in the English Audit Commission report [29]),
and a minority of PCPs routinely used validated instru-
ments to aid diagnosis (47% in Allen et al [28], 44% in the
English Audit Commission report [29]). Olafsdottir et al
[16] showed that 39% of the PCPs questioned thought
that the early detection of dementia was the most difficult
aspect of the condition, and Allen et al [28] showed that
diagnosing the cause of dementia was considered to be
the highest learning need for the PCPs. On the other
hand, 64% of the PCPs in Turner et al's study [30] felt con-
fident in their own ability to make a diagnosis (although
33% of them later went on to support the notion that spe-
cialists ought to be the ones doing this), compared with
o n l y  3 2 %  w h o  f e l t  c o n f i d e n t  i n  a d v i s i n g  o n  s y m p t o m
management. Several conveyed a sense of trepidation
about making a false diagnosis or getting it wrong, and
the effect that this might have on the doctor-patient rela-
tionship [37], or the potential to invoke medico-legal
action [33].
6. Disclosing the Diagnosis
Most studies revealed that PCPs experienced difficulties
in disclosing the diagnosis to the patient or family, for a
variety of reasons. In Iliffe & Wilcock's focus groups [36],
PCPs acknowledged the risks in disclosing a diagnosis at
the wrong place or the wrong time, but also recognised
that sometimes the single act of investigating the patient
for dementia, in itself can enable patients or their families
to understand the possibilities about diagnosis, and may
therefore result in some relief. In Teel's study [35], PCPs
disclosed that often patients or their families will deny
the diagnosis when given to them, often just wanting
themselves/family member "fixed". PCPs might getKoch et al. BMC Family Practice 2010, 11:52
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around this by using euphemistic terms, or reframing the
situation so that priority is given to providing care and
support to the patient rather than a medical label [35,37].
In addition, PCPs conveyed fear that disclosure could
again damage the doctor-patient relationship [33]. In
Allen's focus groups [28], family practitioners suggested a
solution to these issues by proposing a "breaking bad
news" approach to disclosure, but allowing confirmation
of the diagnosis to be made by the specialist. Barriers to
disclosing dementia were also noted in Allen et al's [28]
Canadian research. Whilst 72% of the PCPs routinely
informed family members of the diagnosis, fewer (31%)
informed the patient. The PCP participants in this study
also highlighted approaches to disclosure of the diagnosis
as being their second highest priority learning need. In
contrast, the most frequently identified perceived barrier
to care was the lack of insurance reimbursement for anti-
dementia drugs.
Two other important themes which emerged, but with
less force than the ones above; were delayed presentation
and therapeutic nihilism,
Delayed Presentation
There was a diversity of reasons given for delayed presen-
tation of the patient to primary care services. These
ranged from:
• The patient or family being in denial about there 
being anything wrong [32]
• Families being so immersed in compensating for the 
loss of function of the patient that they don't really 
notice that there is something wrong [35]
• Patients or families not having the knowledge to rea-
lise it is part of a medical condition, or attributing 
symptoms to "normal ageing" [35,33].
Cahill et al [34] specifically asked the PCPs whom they
blamed for delayed diagnoses, and 35% of the PCPs
blamed themselves, with 20% others blaming the family
and 11% blaming the patient. Several of the studies iden-
tified specific characteristics about the PCPs themselves,
their services, or the wider health services that could con-
tribute to the delayed diagnoses. One of the main areas
that arose as potentially acting as a barrier to early diag-
nosis and management was limited knowledge about
dementia.
Therapeutic Nihilism
This describes the attitude on the part of the PCP that
diagnosis is pointless or not worthwhile because there are
no available treatments or benefits to making that diag-
nosis, and so it could in theory cause more harm than
good. Two studies found that this could contribute to
delay in timely diagnosis [34,37]. The English Audit Com-
mission [29] also found that only 52% of PCPs felt that it
was beneficial to make an early diagnosis. It was also
hypothesised that this attitude could hinder PCPs' aware-
ness of local resources and support services, or even
referrals to specialists, in an attempt to protect the
patient or family from intrusive or frightening tests [37].
In addition, Turner et al [30] found that female PCPs were
less likely to express 'heartsink' attitudes, and that the
more experienced PCPs were also more pessimistic.
Discussion
Summary of Findings
In total eleven papers with empirical data were found,
including six qualitative, three quantitative, and two with
mixed methodologies. The six themes from the qualita-
tive studies and the findings from the quantitative studies
can be grouped into doctor factors, patient or societal
factors, and system factors. The former consists of barri-
ers such as diagnostic uncertainty or insufficient knowl-
edge or experience, as well as disclosing the diagnosis,
stigma attached to dementia, and therapeutic nihilism.
Patient or societal factors also include stigma, as well as
delayed presentation which could be because of stigma,
but also because of many other reasons. Finally the sys-
tems (in the countries studied) were responsible for many
of the barriers discovered, including for example, time
constraints and lack of support (which were the most
often-identified factors), as well as financial or remunera-
tion issues.
Strengths & Limitations
This systematic review aimed to investigate what was
known about the barriers to the detection and manage-
ment of dementia, on a background of an established
understanding that PCPs do not achieve high rates of
early detection, and often express difficulties in managing
or following guidelines for dementia patients.
Not all of these studies made explicit the fact that they
were investigating barriers in primary care, and so it was
a strength of the method that abstracts were read through
and articles categorised according to the subject they cov-
ered, in order to limit the omission of relevant data.
Moreover, none of the UK studies were conducted after
the introduction of the dementia domain to the Quality
and Outcomes Framework, which - because of the finan-
cial remuneration attached to maintaining a register of
dementia patients and offering them an annual review -
may influence the way PCPs here approach dementia.
Whilst the search terms used were thought to be broad
enough to capture most relevant publications, it is possi-
ble that there is research that was not caught in our
searches, because of the omission of one or other of the
strata of terminologies, for example, primary care or gen-
eral practi* or family practi*. There was an attempt to
find any missing publications by searching bibliographies
from identified articles, but it is possible that not all rele-Koch et al. BMC Family Practice 2010, 11:52
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vant studies were found. In addition, many of the poten-
tially relevant articles harvested by the search terms were
either in a non-English language, or were not readily
located or available, so possibly some important or perti-
nent research which could have enriched this review has
been missed. However, only a small proportion of studies
were found through searching reference lists, which sug-
gests to us that the literature that we did identify reflects
the current state of our knowledge.
The research was carried out in a variety of countries
all over Europe and North America which could increase
the significance of the common themes identified. Con-
versely, because the PCPs take on different roles and the
health systems are different in each country, it could
make it difficult to extrapolate conclusions about the con-
tribution of those factors to the issues of barriers (and
therefore make the results less generalisable to the UK),
and make future research more difficult to define gener-
ally.
All the reviewed studies had some methodological
weakness. The sample sizes for most studies, including
the quantitative studies, were small on the whole. This is
acceptable in qualitative research, but three of the five
quantitative or mixed studies had fewer than 200 partici-
pants. Furthermore, the recruitment process of some of
the studies lacked robustness. With the qualitative
research, there were attempts to capture the widest
breadth of views with purposive sampling, but some of
the studies resorted to random, snow-balling, or conve-
nient sampling techniques, which would not necessarily
achieve this. Similarly, whilst some of the quantitative
data collection attempts were to recruit generally and
randomly, at times there was potential for selection bias
in the way the researchers identified their sample from
which to recruit.
Implications for the Future
Addressing Patient Barriers
Results from the studies have shown that patients and
families are sometimes responsible, at least partially, for a
delay in diagnosis. The possible reasons for this have
been described earlier, but tend to be due to either the
stigma that is sometimes attached to dementia, or lack of
knowledge on the part of the patients/families. One strat-
egy to eliminate stigma and enhance attendance is by
educating society. There is an overall low level of under-
standing of the condition of dementia in the public and
non-specialist domain which, alongside the stigma that
might be attached, makes it difficult for people to talk
about [1]. There is also uncertainty about the boundary
between normal ageing and cognitive impairment. The
English National Dementia Strategy (NDS) [1] devotes an
entire chapter to "Raising Awareness and Understanding"
(Chapter 3) where it proposes a variety of public informa-
tion campaigns to deliver education about dementia. The
need for this has been corroborated by several other stud-
ies [38,39], and the English Alzheimer's Society carried
out a pilot awareness campaign in 2007, which achieved
positive results [40].
Addressing Doctor Barriers
In spite of policies such as the NDS encouraging the early
detection of dementia, if the PCPs have not been per-
suaded of its validity then they may well not adopt any
attempts to change. Whilst results have demonstrated the
uncertainties that PCPs' face about making a diagnosis,
the benefits (as described earlier) are numerous and per-
suasive and so methods to tackle this hesitancy ought to
be explored. Re-framing the condition may help patients,
family, and practitioners in dealing with the conse-
quences of such a serious position. Iliffe et al [33] offer
the suggestion of re-categorising dementia to a slowly-
progressing disability, rather than a condition or disease,
thus making it more acceptable. Alternatively, rather than
re-framing the condition, de Lepeleire & Heyrman [41]
instead propose re-framing the clinical approach to the
patient, by considering them as a 'frail elderly', thus
enabling an assessment of function alongside the envi-
ronment. This argument goes on to suggest that main-
taining a 'frail balance' with medical, social and
psychological support will be the motivating drive for cli-
nicians who might otherwise adopt a stance of therapeu-
tic nihilism. Another subtle yet potentially effective
adjustment would be to modify the terminology used
from 'diagnosis' to 'recognition' [33]. This would convey a
dynamic process, which is continuing rather than finite,
may rely on multiple assessments, and would offer more
than just a label; an opportunity to manoeuvre the patient
and family into a position of acceptance of their situation
as well as being receptive to help and support that is avail-
able to them.
Results suggest that important areas for future research
and development ought to be effective educational and
support measures for PCPs. Because the incidence of
dementia means that, for example, on average each Brit-
ish GP will encounter only 1-2 newly diagnosed (or
potential to be diagnosed with) dementia patients annu-
ally, learning from experience cannot be relied upon as an
effective educational tool. Instead, educational strategies
need to be targeted to PCPs in a way that will effect a
change in their clinical practice. Much of the material
generated by the PCPs revealed a concern about their
own abilities to make a diagnosis of, or manage a patient
with, dementia. This was corroborated quantitatively, but
even then the data was reflective of PCPs' perceptions of
their knowledge, rather than their actual knowledge or
training. Because there is no one particular screening
instrument that is recommended for use, because there is
no definitive diagnostic test, and because dementia isKoch et al. BMC Family Practice 2010, 11:52
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more of a syndrome than a disease, it is easy to imagine
how uncertainty amongst clinicians who do not deal with
it regularly might arise. This, dovetailed with the inherent
stigma and apprehension about making a wrong diagno-
sis and disclosing the diagnosis with aptitude and empa-
thy, seems to be the font of insecurities that make PCPs
reluctant or unable at times to recognise dementia earlier.
So, rather than simply augmenting clinical knowledge,
educational interventions should ideally be more attitudi-
nal, focusing on enhancing PCPs' perceptions of their
suitability and ability to make the diagnosis, and the value
of doing so in a timely manner.
Addressing System Barriers
Much of the difficulty in detecting and managing demen-
tia for PCPs arises from the health systems in which they
work, rather than their own abilities, and this was a senti-
ment that was expressed by PCPs from Europe as well as
North America. In many cases, part of the problem was
due to the way the primary care system was organised or
arranged, for example, with timings and finances. How-
ever, most of the systemic obstacles stemmed from a feel-
ing of lack of support from and communication with
secondary specialist care. In addition, it has been sug-
gested that diagnosis would be best-achieved by a two-
step process, where the PCP detects cognitive impair-
ment and loss of function and suspects dementia, but the
actual diagnosis and sub-typing is confirmed by a special-
ist [42]; this could lead to confusion, and is dependent
upon good communication and access between the gen-
eralist and specialist. To some extent, services provided
will be dependent on local provisions, demography, and
geography, but even if the services are available, if the
relationship or understanding of expectations between
the generalists and specialists is dysfunctional, then
patients will not receive the high quality of care that they
deserve [33]. Therefore, there is potential to conduct
research into what support PCPs envisage as being help-
ful, their perceptions and expectations around their rela-
tionship with secondary care, and what they feel they
would need in order to feel confident about detecting and
managing dementia. Shared care protocols would be one
technique that could be used to attempt to divide care
appropriately between the generalist and the specialist,
but which could provide the PCP with the knowledge and
support that they need. This has been substantiated by
Renshaw et al [43] who discovered that if the local sec-
ondary services had made contact with and gave educa-
tion about dementia to their local PCPs, the PCPs were
significantly more likely to view early diagnosis as benefi-
cial compared to those that hadn't. Presumably, through
the process of development of local protocols the roles of
primary and secondary care in diagnosis and manage-
ment will be discussed and defined, providing much-
needed clarity for all potential stakeholders [44]. In addi-
tion it has been suggested that referral pathways are more
effective than simple guidelines, and that a clear and
robust multi-disciplinary infrastructure will enable diag-
nosis and management [45], and enhance patient and
caregiver satisfaction [31]. Research can be carried out in
order to establish effective educational tools which will
reinforce the advantages of shared care, and the use of
multi-disciplinary teamwork for management.
Conclusion
Understanding the factors that can promote diagnostic
delay could inform intervention studies, which we will
investigate further in a separate review. However, the
ways in which the main factors interact may determine
the timeliness of diagnosis, so further research could use-
fully address this, perhaps using significant event analysis
methods in cases of late presentation and very early diag-
nosis.
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